IMS Health

Cegedim achieves solid growth in first quarter 2024

Retrieved on: 
Thursday, April 25, 2024

On February 15, 2024, Cegedim Santé acquired Visiodent, a leading provider of management solutions for dental practices and health clinics in France.

Key Points: 
  • On February 15, 2024, Cegedim Santé acquired Visiodent, a leading provider of management solutions for dental practices and health clinics in France.
  • Visiodent generated revenue of c.€10 million in 2023 and began contributing to Cegedim Group’s consolidation scope on March 1, 2024.
  • Based on the currently available information, the Group expects 2024 like-for-like revenue(1) growth to be in the range of 5-8% relative to 2023.
  • WEBCAST IN ENGLISH ON APRIL 25, 2024, AT 6:15 PM (PARIS TIME)
    The webcast is available at: www.cegedim.fr/webcast
    The Q1 2024 revenue presentation is available on the website:
    The Audit Committee met on April 25, 2024.

Arsenal Capital Partners Adds Raymond H. Hill as an Operating Partner

Retrieved on: 
Thursday, April 18, 2024

NEW YORK, April 18, 2024 /PRNewswire/ -- Arsenal Capital Partners ("Arsenal"), a leading private equity firm specializing in building technology-rich, market-leading healthcare and industrial growth companies, today announced that it has expanded its team with the addition of Raymond ("Ray") H. Hill.

Key Points: 
  • NEW YORK, April 18, 2024 /PRNewswire/ -- Arsenal Capital Partners ("Arsenal"), a leading private equity firm specializing in building technology-rich, market-leading healthcare and industrial growth companies, today announced that it has expanded its team with the addition of Raymond ("Ray") H. Hill.
  • Mr. Hill will work as an Operating Partner within the firm's healthcare team and will focus on pharmaceutical services investment themes and portfolio companies.
  • Mr. Hill was most recently Chairman and CEO of CorEvitas, LLC ("CorEvitas").
  • Gene Gorbach, an Investment Partner of Arsenal, stated, "We are incredibly excited to welcome Ray to our team.

Cegedim Full year 2023 results: Revenue and recurring operating income both up

Retrieved on: 
Wednesday, March 27, 2024

The division’s recurring operating income climbed 33%, bolstered mainly by outsourcing for HR departments, which is riding a wave of management process automation.

Key Points: 
  • The division’s recurring operating income climbed 33%, bolstered mainly by outsourcing for HR departments, which is riding a wave of management process automation.
  • Sales to insurers posted positive recurring operating income, up slightly, despite the costs of launching the Allianz contract.
  • 2023 recurring operating income was a €4.5 million loss, €1.1 million higher than the loss in 2022.
  • Visiodent generated revenue of c.€10 million in 2023 and will begin contributing to Cegedim Group’s consolidation scope on March 1, 2024.

ODAIA Attracts Top Talent to Accelerate Next Phase of Innovation and Customer Success

Retrieved on: 
Tuesday, February 6, 2024

TORONTO, Feb. 6, 2024 /PRNewswire/ -- ODAIA today announced it expanded its strategic alliances, product management, and marketing leadership teams to help address customers' most strategic challenges in commercial operations. The company is bringing together accomplished life sciences industry experts and proven SaaS technology leaders to accelerate innovation and customer success in Customer Science, an emerging business discipline that integrates data science, behavioral science, and AI to drive healthcare professional (HCP) engagement.

Key Points: 
  • The company is bringing together accomplished life sciences industry experts and proven SaaS technology leaders to accelerate innovation and customer success in Customer Science , an emerging business discipline that integrates data science, behavioral science, and AI to drive healthcare professional (HCP) engagement.
  • The ODAIA Customer Science cloud solution, MAPTUAL , gives sales and marketing advanced, AI-driven insights and predictions for a comprehensive understanding of HCP prescribing patterns and behavioral trends.
  • ODAIA continues to attract top talent to drive the next phase of innovation in Customer Science and help advance pharma customers' commercial strategies.
  • He leads the development of ODAIA industry solutions and market strategy, as well as strategic relationships with customers and partners.

22-Provider Integrated Medical Health Reports Significant Increase in Growth and Value Using eClinicalWorks and healow Solutions

Retrieved on: 
Tuesday, October 24, 2023

eClinicalWorks® , the largest ambulatory cloud EHR, today announced that Integrated Medical Health (IM | Health) — a 22-provider primary care clinic in Wayne, PA — significantly grew its multi-specialty practice using eClinicalWorks EHR and healow patient engagement solutions .

Key Points: 
  • eClinicalWorks® , the largest ambulatory cloud EHR, today announced that Integrated Medical Health (IM | Health) — a 22-provider primary care clinic in Wayne, PA — significantly grew its multi-specialty practice using eClinicalWorks EHR and healow patient engagement solutions .
  • IM | Health provides comprehensive primary care to its patients, including urgent care, physical therapy, nutrition counseling, behavioral health, personal training, and massage.
  • IM | Health uses the healow® suite of patient engagement tools — a comprehensive, EHR-agnostic, cloud-based platform for patients, practices, payers, hospitals, and health systems.
  • Recently, the company added healow Pay™ to streamline online billing, allowing patients to pay their medical bills via text message, email, or by website.

SES Appoints Adel Al-Saleh as CEO

Retrieved on: 
Friday, October 13, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231012234351/en/
    SES, a leading provider of global content connectivity solutions, today announced that Adel Al-Saleh has been hired as the company’s Chief Executive Officer, effective February 2024.
  • Interim SES CEO Ruy Pinto, who served as SES’s Chief Technology Officer from 2019 to 2023, will continue to lead SES through January 2024, after which Pinto will remain as a member of the executive team until June 2024 and then will assume the role of strategic advisor to the CEO.
  • Frank Esser, Chairman of the SES Board of Directors, said, “We are delighted to welcome Adel Al-Saleh as our new CEO.
  • This makes Adel the ideal person to lead SES into the next phase of our journey and deliver success.”
    Esser continued, “On behalf of the Board, I want to thank Ruy for his continuing leadership.

Sage Growth Partners Announces Hiring of Industry Executive Jennifer Walsh as new Senior Vice President of Sales

Retrieved on: 
Tuesday, September 19, 2023

BALTIMORE, Sept. 19, 2023 /PRNewswire/ -- Sage Growth Partners (SGP), a Baltimore-based healthcare research, strategy, and marketing firm, is pleased to announce the hiring of Jennifer Walsh as its new Senior Vice President of Sales.

Key Points: 
  • BALTIMORE, Sept. 19, 2023 /PRNewswire/ -- Sage Growth Partners (SGP), a Baltimore-based healthcare research, strategy, and marketing firm, is pleased to announce the hiring of Jennifer Walsh as its new Senior Vice President of Sales.
  • "Jennifer brings with her a tremendous wealth of knowledge about the healthcare industry," said Dan D'Orazio, Sage Growth Partners CEO.
  • "I am very excited to join Sage Growth Partners and begin immediately contributing to the firm's new business acquisition and agency growth.
  • I believe our future is ripe for continued success and the time is right for new business growth," said Walsh.

CIEN+ Recognized by MM+M as Top 100 Healthcare Marketing Agency in North America

Retrieved on: 
Monday, June 26, 2023

DALLAS, June 26, 2023 /PRNewswire/ -- CIEN+ announces it has been recognized by Medical Marketing and Media (MM+M) in their 2023 Top 100 Healthcare Marketing Agencies in North America. Inclusion on the MM+M Agency 100 list confirms CIEN+'s leadership providing innovative research technologies and creative solutions for pharmaceutical and healthcare companies that want to accelerate their impact and commercial growth by tapping into the power of diverse market segments.

Key Points: 
  • DALLAS, June 26, 2023 /PRNewswire/ -- CIEN+ announces it has been recognized by Medical Marketing and Media (MM+M) in their 2023 Top 100 Healthcare Marketing Agencies in North America.
  • CIEN+ stands out as the only agency on the list that is independent, 100% Hispanic-owned, and founded and certified by the NMSDC Corporate Plus® and WBENC.
  • The agency is also #1 as the fastest-growing healthcare agency on the list based on a reported percentage change of 130%.
  • powered insights, business strategy, inclusive marketing and media, and the activation of an extensive network for community engagement.

Ambrx Appoints Stephen Glover as Chairman of its Board of Directors

Retrieved on: 
Thursday, May 18, 2023

SAN DIEGO, May 18, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced that Stephen Glover has joined the Company’s Board of Directors as Chairman.

Key Points: 
  • SAN DIEGO, May 18, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced that Stephen Glover has joined the Company’s Board of Directors as Chairman.
  • The Company’s former Chair, Katrin Rupalla, Ph.D., has resigned from Ambrx’s Board of Directors to pursue another opportunity, which precludes her ability to serve on any boards of directors.
  • Stephen Glover’s experience spans Fortune 100, start-up and entrepreneurial environments and his transaction experience covers over 25 transactions.
  • Mr. Glover is Chairman of the Board of Directors of PDS Biotechnology and a Board member of the Coulter Foundation at the University of Miami U Innovation Center.

Cegedim: Full year 2022 results

Retrieved on: 
Thursday, March 23, 2023

Corporate and others: 2022 REBIT(1) was a €3.4 million loss, €2.3 million higher than the loss in 2021.

Key Points: 
  • Corporate and others: 2022 REBIT(1) was a €3.4 million loss, €2.3 million higher than the loss in 2021.
  • To the best of the company’s knowledge, there were no events or changes during 2022 that would materially alter the Group’s financial situation.
  • On May 16, 2022, Cegedim Group and social protection companies Malakoff Humanis, Groupe VYV, and PRO BTP Groupe announced that they had finalized the strategic partnership they began negotiating on March 1, 2022.
  • The webcast is available at: www.cegedim.fr/webcast
    The fiscal 2022 results presentation is available:
    And on the Cegedim IR smartphone app, available at https://www.cegedim.fr/finance/profil/Pages/CegedimIR.aspx